Search: onr:"swepub:oai:DiVA.org:uu-371061" >
Co-localisation of ...
-
Koyi, HirshKarolinska Institutet,Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Gavle Cent Hosp, Dept Resp Med, S-80187 Gavle, Sweden;Karolinska Inst, Stockholm, Sweden
(author)
Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer
- Article/chapterEnglish2018
Publisher, publication year, extent ...
-
2018-05-30
-
Anticancer Research USA Inc.2018
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-371061
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-371061URI
-
https://doi.org/10.21873/anticanres.12600DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:139540981URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Aim: Accurate classification of lung carcinomas is crucial for selecting appropriate and adequate chemotherapy treatment. In this study, glandular (adenocarcinoma), and squamous cell differentiation were examined in non-small cell lung carcinoma (NSCLC) without obvious light-microscopic signs of squamous and glandular differentiation. Materials and Methods: All lung tumours diagnosed as NSCLC (n=61), without obvious squamous or glandular features, were obtained by bronchial biopsy or core biopsy supported by computed tomography. They were diagnosed during 1996-2009, at the Department of Pathology, Gavle Hospital, Sweden. The tumours were examined immunohistochemically with antibodies against CK5/6, p63 (squamous cell markers) and carcinoembryonic antigen (CEA) (adenocarcinoma cell marker). Double immunostaining (p63/CEA) was also performed on individual tumours. Results: The tumours originated from 36 males and 25 females, aged 54-83 years. Pure squamous cell differentiation (CK5/6 positive only) occurred in 34.4% (n=21) tumours and pure adenocarcinoma cell differentiation (CEA positive only) was present in 14.9% (n=9). Tumours with both squamous and adenocarcinoma features (CK5/6 and CEA positive) were most prevalent (47.5%, n=29). Two tumours (3.3%) were negative with both stains (and also synaptophysin negative). Double immunostaining (p63/CEA) revealed that squamous and adenocarcinoma markers were co-localised in cells in certain tumours. Conclusion: Co-localisation of squamous and adenocarcinoma markers in the same tumour cell suggests that additional analyses for novel biomarkers of specific lung cancer types may subsequently lead to a refined treatment choice for patients with the goal of improving clinical outcomes.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Brandén, EvaUppsala universitet,Centrum för klinisk forskning, Gävleborg,Gavle Cent Hosp, Dept Resp Med, S-80187 Gavle, Sweden;Karolinska Inst, Stockholm, Sweden(Swepub:uu)evabr789
(author)
-
Kasim, IhsanGavle Cty Hosp, Dept Pathol, Gavle, Sweden
(author)
-
Wilander, ErikGavle Cty Hosp, Dept Pathol, Gavle, Sweden
(author)
-
Uppsala universitetCentrum för klinisk forskning, Gävleborg
(creator_code:org_t)
Related titles
-
In:Anticancer Research: Anticancer Research USA Inc.38:6, s. 3341-33460250-70051791-7530
Internet link
Find in a library
To the university's database